Who Paid My Doc
Kakit Wong
Nuclear Medicine Ann Arbor, MI Medical Doctor
NPI 1033230768 CMS profile 1246525
1500 E Medical Center Dr, B1 Floor University Hospital Room B1g412, Ann Arbor, MI 48109
General payments
$0
Research payments
$3,614
Ownership & investment interest
$0
Research they led as principal investigator
$42,750
Through program year 2025, Kakit Wong of Ann Arbor, MI is reported in the CMS Open Payments database as having received $0 across 0 general payments and $3,614 in research payments paid to them. Separately, studies naming them as principal investigator received $42,750 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 83rd percentile of Nuclear Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | Research | $3,614 | 1 |
Prescribing to Medicare patients
Part D · data year 2024 · 2 drugsPart D claims
30
Drug cost
$422
Branded share of claims
53.3%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Levoxyl Levothyroxine Sodium | Brand | 16 | $398 | |
| Ondansetron Hcl | Generic | 14 | $24 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero.
Billing to Medicare
Part B · data year 2024 · 31 billing codesPaid by Medicare
$40,271
Medicare patients
764
Services billed
913
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 64% | |
| Cancer | 38% | |
| Arthritis | 38% | |
| Diabetes | 24% | |
| Osteoporosis | 23% | |
| Chronic kidney disease | 22% | |
| Depression | 21% | |
| Ischemic heart disease | 20% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Nuclear Medicine in Michigan
Related records
Nuclear Medicine in Michigan
Practitioners in the same specialty and state, ranked by reported value.
All Nuclear Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Michigan
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.